Electronic health record-derived machine learning model for hypoglycemia risk prediction in type 2 diabetes mellitus patients: development and validation.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: EHR-derived machine-learning models predicted hypoglycemia risk among type-2 diabetes patients with a validation cohort.
Technology: BackgroundHypoglycemia is a serious complication of diabetes. Early recognition of hypoglycemia can improve clinical prognosis, however, traditional diagnostic tools are often limited. Machine learning offers a promising approach for predicting adverse outcomes in diabetic patients.ObjectiveThis study aims to develop and validate machine learning-based models to predict the risk of hypoglycemia in type 2 diabetes mellitus (T2DM) patients.MethodsA cohort study design was employed. Clinical…
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Four classifiers applied electronic health record variables to estimate hypoglycemia risk in adults with type 2 diabetes; the study compared them using a 70:30 internal train-validation split.
- Limitation / still unknown
- The 831-patient EHR dataset was randomly split 70:30 within one study setting; no external validation or clinical-impact evaluation is reported.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13435572/ · https://europepmc.org/article/MED/42218408
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.